ClinicalTrials.Veeva

Menu

Endtidal Ethanol in Sclerotherapy

I

Insel Gruppe AG, University Hospital Bern

Status

Completed

Conditions

Ethanol Concentration

Treatments

Device: Alcomed 3011®

Study type

Observational

Funder types

Other

Identifiers

NCT02740855
Endtidal ethanol

Details and patient eligibility

About

During the ethanol sclerotherapy procedure, the investigators will record doses of and time of ethanol injections and record ethanol concentrations in endtidal breath every 5 minutes. Furthermore after every ethanol injection the concentration will be measured every minute for 5 minutes. To do so, the investigators will attach a breath alcohol testing device to the expiratory carbon dioxide measuring unit. Since this is the new standard of the university hospital Berne all patients undergo the same procedure. There is no study specific intervention. In this study the investigators will only document the breath alcohol levels, doses and timing of ethanol injections. All other data will be obtained from the anesthesia information system. During the two months of the study, the investigators will also record endtidal ethanol concentration after anesthesia in the postoperative care unit discharge from the unit.

The intention is to show the correlation between injected ethanol doses and measured endtidal ethanol concentration over the entire time of the intervention.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • undergoing ethanol sclerotherapy at the university hospital Berne

Exclusion criteria

  • under the age of 18

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems